Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-11-10

FDA Approved: BRINZOLAMIDE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

The FDA approved a supplemental application for brinzolamide submitted by Sandoz Inc under NDA 020816, reflecting an approved modification to the existing produ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Brinzolamide (Brinzolamide)

Snippet

SUPPL AP for BRINZOLAMIDE (BRINZOLAMIDE)